Troxacitabine

Last updated
Troxacitabine
Troxacitabine.svg
Identifiers
  • 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2(1H)-one
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C8H11N3O4
Molar mass 213.193 g·mol−1
3D model (JSmol)
  • O=C1/N=C(/N)\C=C/N1[C@H]2O[C@H](OC2)CO
  • InChI=1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1 Yes check.svgY
  • Key:RXRGZNYSEHTMHC-BQBZGAKWSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases. [1]

References

  1. Vose JM, Panwalkar A, Belanger R, Coiffier B, Baccarani M, Gregory SA, et al. (January 2007). "A phase II multicenter study of troxacitabine in relapsed or refractory lymphoproliferative neoplasms or multiple myeloma". Leukemia & Lymphoma. 48 (1): 39–45. doi:10.1080/10428190600909578. PMID   17325846. S2CID   36220728.